137 related articles for article (PubMed ID: 28685276)
1. Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.
Mizrak Kaya D; Dong X; Nogueras-González GM; Xu Y; Estrella JS; Harada K; Lopez A; Amlashi FG; Hofstetter WL; Maru DM; Nguyen QN; Lee JH; Weston B; Bhutani MS; Erasmus JJ; Thomas I; Rogers JE; Song S; Ajani JA
Med Oncol; 2017 Aug; 34(8):135. PubMed ID: 28685276
[TBL] [Abstract][Full Text] [Related]
2. Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma.
Shiozaki H; Slack R; Sudo K; Elimova E; Wadhwa R; Chen HC; Skinner HD; Komaki R; Lee JH; Weston B; Bhutani MS; Blum MA; Rogers JE; Maru DM; Hofstetter WL; Ajani JA
Oncology; 2015; 88(6):332-6. PubMed ID: 25765098
[TBL] [Abstract][Full Text] [Related]
3. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Diagn Cytopathol; 2013 Mar; 41(3):199-205. PubMed ID: 21964981
[TBL] [Abstract][Full Text] [Related]
4. Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma.
Schiffmann LM; Göbel H; Löser H; Schorn F; Werthenbach JP; Fuchs HF; Plum PS; Bludau M; Zander T; Schröder W; Bruns CJ; Kashkar H; Quaas A; Gebauer F
BMC Cancer; 2019 May; 19(1):531. PubMed ID: 31151416
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.
Liu Y; Su Z; Li G; Yu C; Ren S; Huang D; Fan S; Tian Y; Zhang X; Qiu Y
Int J Cancer; 2013 Aug; 133(3):671-9. PubMed ID: 23364922
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma.
Yakirevich E; Lu S; Allen D; Mangray S; Fanion JR; Lombardo KA; Safran H; Resnick MB
Hum Pathol; 2017 Aug; 66():126-135. PubMed ID: 28666927
[TBL] [Abstract][Full Text] [Related]
7. Metadherin expression and lung relapse in patients with colorectal carcinoma.
Casimiro S; Fernandes A; Oliveira AG; Franco M; Pires R; Peres M; Matias M; Tato-Costa J; Guerra N; Ramos M; Cruz J; Costa L
Clin Exp Metastasis; 2014 Aug; 31(6):689-96. PubMed ID: 24946951
[TBL] [Abstract][Full Text] [Related]
8. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
10. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder].
Liu DC; Yang ZL
Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571
[TBL] [Abstract][Full Text] [Related]
11. Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.
Ong CA; Shapiro J; Nason KS; Davison JM; Liu X; Ross-Innes C; O'Donovan M; Dinjens WN; Biermann K; Shannon N; Worster S; Schulz LK; Luketich JD; Wijnhoven BP; Hardwick RH; Fitzgerald RC
J Clin Oncol; 2013 Apr; 31(12):1576-82. PubMed ID: 23509313
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.
Prins MJ; Verhage RJ; ten Kate FJ; van Hillegersberg R
J Gastrointest Surg; 2012 May; 16(5):956-66. PubMed ID: 22258871
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
Neishaboori N; Wadhwa R; Nogueras-González GM; Elimova E; Shiozaki H; Sudo K; Charalampakis N; Hiremath A; Lee JH; Bhutani MS; Weston B; Blum MA; Rogers JE; Garris JL; Rice DC; Komaki R; Swisher SG; Skinner HD; Hofstetter WL; Ajani JA
Oncology; 2015; 89(2):65-9. PubMed ID: 25765719
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.
Malhotra U; Zaidi AH; Kosovec JE; Kasi PM; Komatsu Y; Rotoloni CL; Davison JM; R C; Irvin ; Hoppo T; Nason KS; Kelly LA; Gibson MK; Jobe BA
PLoS One; 2013; 8(11):e78343. PubMed ID: 24223792
[TBL] [Abstract][Full Text] [Related]
15. Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma.
Xi M; Hallemeier CL; Merrell KW; Liao Z; Murphy MAB; Ho L; Hofstetter WL; Mehran R; Lee JH; Bhutani MS; Weston B; Maru DM; Komaki R; Ajani JA; Lin SH
Ann Surg; 2018 Aug; 268(2):289-295. PubMed ID: 28628563
[TBL] [Abstract][Full Text] [Related]
16. High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary thyroid carcinoma.
Li WF; Wang G; Zhao ZB; Liu CA
Clin Endocrinol (Oxf); 2015 Oct; 83(4):572-80. PubMed ID: 25418110
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
18. Association of MTDH immunohistochemical expression with metastasis and prognosis in female reproduction malignancies: a systematic review and meta-analysis.
Hou Y; Yu L; Mi Y; Zhang J; Wang K; Hu L
Sci Rep; 2016 Dec; 6():38365. PubMed ID: 27917902
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.
Underwood TJ; Hayden AL; Derouet M; Garcia E; Noble F; White MJ; Thirdborough S; Mead A; Clemons N; Mellone M; Uzoho C; Primrose JN; Blaydes JP; Thomas GJ
J Pathol; 2015 Feb; 235(3):466-77. PubMed ID: 25345775
[TBL] [Abstract][Full Text] [Related]
20. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]